CRO Regulatory Requirements MCQs With Answer

CRO Regulatory Requirements MCQs With Answer is designed for M. Pharm students to deepen their understanding of the regulatory, quality and intellectual property considerations when working with Contract Research Organizations (CROs). This set of focused multiple-choice questions covers key areas such as GCP/GLP/GMP compliance, data integrity, electronic records, contracts (NDA, MTA, CTA), pharmacovigilance reporting, national and international regulatory authorities, accreditation, and audit strategies. Each question emphasizes practical regulatory expectations and IP protections relevant to outsourced research services, helping students prepare for real-world CRO oversight, sponsor responsibilities and contractual arrangements while strengthening exam readiness for MIP 104T – Intellectual Property Rights.

Q1. Which international guideline is the primary standard for the conduct of clinical trials by CROs to ensure participant protection and data quality?

• OECD GLP
• GMP
• ICH-GCP (E6)
• ISO 9001

Correct Answer: ICH-GCP (E6)

Q2. Which regulatory framework is specifically intended for nonclinical safety laboratory studies performed by CROs?

• ICH-GCP
• OECD GLP
• ICH Q1A
• GMP

Correct Answer: OECD GLP

Q3. When a sponsor outsources clinical trial activities to a CRO, who ultimately retains regulatory responsibility for the trial?

• The CRO
• The contract research coordinator
• The institutional ethics committee
• The sponsor

Correct Answer: The sponsor

Q4. Which contract is commonly used to protect confidential information and sponsor intellectual property when sharing study materials with a CRO?

• Material Transfer Agreement (MTA)
• Non-Disclosure Agreement (NDA) / Confidentiality Agreement
• Standard Operating Procedure (SOP)
• Clinical Trial Agreement (CTA)

Correct Answer: Non-Disclosure Agreement (NDA) / Confidentiality Agreement

Q5. Which US regulation sets requirements for electronic records and electronic signatures that CROs must follow when handling computerized data?

• 21 CFR Part 11
• GDPR
• HIPAA
• ICH E6(R2)

Correct Answer: 21 CFR Part 11

Q6. Which data integrity acronym emphasizes that recorded data should be Attributable, Legible, Contemporaneous, Original and Accurate (and often extended to include Complete/Consistent/Available)?

• ALARA
• ALCOA-C
• CAPA
• GxP

Correct Answer: ALCOA-C

Q7. Which Indian regulatory authority is primarily responsible for approval and oversight of clinical trials conducted by CROs?

• ICMR (Indian Council of Medical Research)
• DBT (Department of Biotechnology)
• DCGI / CDSCO (Central Drugs Standard Control Organization)
• NABL

Correct Answer: DCGI / CDSCO (Central Drugs Standard Control Organization)

Q8. What is the primary mechanism to define intellectual property ownership and rights between a sponsor and a CRO?

• Patent office default ownership rules
• Verbal project agreement
• Contractual agreement (clearly defined IP clauses)
• Regulatory guidance documents

Correct Answer: Contractual agreement (clearly defined IP clauses)

Q9. For Suspected Unexpected Serious Adverse Reactions (SUSARs) that are fatal or life-threatening, what is the usual regulatory reporting timeframe to authorities in major jurisdictions?

• 7 calendar days
• 30 calendar days
• 90 calendar days
• Within one year

Correct Answer: 7 calendar days

Q10. Which element is a key component of a CRO quality management system to address detected nonconformities and prevent recurrence?

• Marketing plan
• Profit-sharing arrangement
• Corrective and Preventive Action (CAPA)
• Clinical registration

Correct Answer: Corrective and Preventive Action (CAPA)

Q11. Which ICH guideline specifically includes expectations for monitoring, sponsor oversight and responsibilities for clinical trials carried out by CROs?

• ICH Q9 (Quality Risk Management)
• ICH E6 (Good Clinical Practice)
• ICH M4 (Common Technical Document)
• ICH Q1A (Stability)

Correct Answer: ICH E6 (Good Clinical Practice)

Q12. What is essential for GLP-compliant nonclinical laboratory data generated by a CRO?

• Marketing authorization
• Traceability and preservation of raw data (audit trail)
• Clinical trial registration
• Immediate publication of results

Correct Answer: Traceability and preservation of raw data (audit trail)

Q13. Which requirement is a core provision of 21 CFR Part 11 that affects CRO electronic systems?

• Good Distribution Practices for samples
• Requirements for electronic records and electronic signatures
• Standards for animal welfare
• Clinical trial insurance requirements

Correct Answer: Requirements for electronic records and electronic signatures

Q14. Which regulation governs protection and lawful cross-border transfer of personal data for subjects in European trials handled by CROs?

• GDPR (General Data Protection Regulation)
• HIPAA
• ICH E2A
• 21 CFR Part 11

Correct Answer: GDPR (General Data Protection Regulation)

Q15. Which Indian accreditation body commonly certifies analytical and bioanalytical laboratories that CROs operate for testing and data credibility?

• NABL (National Accreditation Board for Testing and Calibration Laboratories)
• DCGI
• CDSCO
• NACO

Correct Answer: NABL (National Accreditation Board for Testing and Calibration Laboratories)

Q16. When biological materials are transferred from a sponsor to a CRO, which agreement sets terms for permitted use, ownership, and IP arising from those materials?

• Non-Disclosure Agreement (NDA)
• Material Transfer Agreement (MTA)
• Clinical Trial Agreement (CTA)
• Service Level Agreement (SLA)

Correct Answer: Material Transfer Agreement (MTA)

Q17. According to ICH E6(R2), for how long should a sponsor typically retain essential documents in the Trial Master File after the last approval in an ICH region?

• 2 years
• 6 months
• 10 years
• Indefinitely with no guidance

Correct Answer: 2 years

Q18. Which contractual document between a sponsor and a CRO defines the scope of work, responsibilities, timelines and payment for a clinical study?

• Clinical Trial Agreement (CTA)
• Standard Operating Procedure (SOP)
• Non-Disclosure Agreement (NDA)
• Material Transfer Agreement (MTA)

Correct Answer: Clinical Trial Agreement (CTA)

Q19. Which manufacturing standard must be followed for production of investigational medicinal products to ensure quality and patient safety?

• Good Manufacturing Practice (GMP)
• Good Laboratory Practice (GLP)
• Good Clinical Practice (GCP)
• Good Distribution Practice (GDP)

Correct Answer: Good Manufacturing Practice (GMP)

Q20. What is the recommended approach for determining the frequency and scope of sponsor audits of CRO operations?

• Fixed annual audits regardless of risk
• Only a single pre-study audit
• Risk-based periodic audits and oversight
• No audits if a contract exists

Correct Answer: Risk-based periodic audits and oversight

Download